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AbstrACt
Introduction Type 2 diabetes mellitus is a major source 
of morbidity and mortality in South Africa, spurred by 
increased urbanisation and unhealthy lifestyle factors. 
Local epidemiological data are required to inform health 
planning and policy. The purpose of this systematic review 
is to identify, collate and synthesise all studies reporting 
the prevalence of diabetes in South Africa. A secondary 
aim is to report the prevalence of impaired glucose 
tolerance and impaired fasting glucose, conditions which 
are associated with an increased risk of progression 
to overt diabetes, and the prevalence of undiagnosed 
diabetes.
Methods and analysis Multiple databases will be 
searched for diabetes prevalence studies conducted in 
South Africa between 1997 and 2018. Two authors will 
independently select studies that meet the inclusion 
criteria, extract data and appraise studies using a risk 
of bias tool for prevalence studies. Studies with low 
or moderate risk of bias will be included. Sources of 
heterogeneity will be explored using subgroup analysis.
Ethics and dissemination The systematic review does 
not require ethics clearance since published studies with 
non-identifiable data will be used. This review will provide 
best estimates to inform the Second National Burden of 
Disease study which can guide health and policy planning.
PrOsPErO registration number CRD42017071280
IntrOduCtIOn 
Diabetes mellitus, a condition characterised by 
raised blood glucose levels, is a major source 
of morbidity, mortality and health costs world-
wide. The International Diabetes Federation 
estimates that in 2017, 451 million adults 
worldwide had diabetes, with projections of 
693 million cases by 2045.1 Globally, approxi-
mately 50% of diabetes cases are undiagnosed, 
with the majority of these occurring in low-in-
come and middle-income countries. In Africa, 
the proportion of undiagnosed diabetes is 
69.2%. Furthermore, 77% of deaths due to 
diabetes in Africa occurred in individuals 
younger than 60 years of age,1 emphasising the 
magnitude of the diabetes epidemic. In Africa, 
as in other parts of the world, type 2 diabetes 
represents over 90% of diabetes cases.2 3 
The prevalence of diabetes is rapidly 
increasing in South Africa. In 2009, approx-
imately 2 million (9%) people aged 30 years 
and older had diabetes,4 increasing almost 
twofold since 2000 when Bradshaw et al 
reported a prevalence of 5.5%.5 Several factors 
such as the ageing population, economic 
transition and urbanisation associated with 
nutrition transition and obesity have contrib-
uted to the increased diabetes prevalence.6–9 
In 2000, it was estimated that 87% of diabetes 
cases in South Africa were attributed to excess 
body weight.10 This is concerning since in 
2013 ~38% of men and ~69% of women in 
South Africa were considered overweight or 
obese.11 In 2015, the global burden of disease 
study estimated that high body mass index 
and hyperglycaemia, ranked as the second 
and third leading risk factors, respectively, 
after unsafe sex, for early death and disability 
in South Africa.12
Diabetes, due to its association with several 
microvascular and macrovascular compli-
cations, places a significant burden on the 
South African health system. In 2009, it 
was estimated that diabetes caused about 
8000 new cases of blindness and 2000 new 
cases of amputations annually.4 A national 
strengths and limitations of this study
 ► The first ever systematic review of type 2 diabetes
prevalence in South Africa.
 ► A comprehensive synthesis of all available diabetes
prevalence data in South Africa using a standardised 
risk of bias tool.
 ► The protocol adheres to Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
Protocols guidelines.
 ► The quality of the review will be assessed using
the Grading of Recommendations Assessment,
Development and Evaluation.
 ► The heterogeneity in diagnostic criteria, study dates, 
age of study participants and population groups may 
limit comparison across studies.
2 Pheiffer C, et al. BMJ Open 2018;8:e021029. doi:10.1136/bmjopen-2017-021029
Open access 
burden of disease study in 2000 reported that diabetes 
accounted for approximately 14% of cases of ischaemic 
heart disease, 10% of stroke, 12% of hypertensive disease 
and 12% of renal disease.5 Furthermore, the indirect 
costs of diabetes are high. Diabetes in Africa affect mainly 
working-aged people between 40 and 60 years of age9 
placing an added burden on the economy due to work 
absenteeism and decreased productivity. South Africa 
is battling a quadruple burden of disease due to high 
rates of infectious diseases, non-communicable disease, 
maternal and child mortality, and injury-related disor-
ders, thus have limited resources to meet the increased 
health and economic costs of diabetes.13
rationale
Urgent action is required to halt the burgeoning diabetes 
epidemic in South Africa. The feasibility of popula-
tion-level interventions, particularly those aimed at 
prevention is widely reported.14 However, such initiatives 
are hampered by the lack of epidemiological data, a chal-
lenge faced by all countries in Africa.15 Several studies 
have measured the prevalence of diabetes in South 
Africa,16–26 although they were conducted in different 
geographical areas (urban vs rural), among different 
population groups and are generally too small to indi-
vidually give generalisable prevalence data. Pooling 
of existing data is considered an effective strategy to 
generate representative and robust prevalence figures.8 
Bertram et al calculated the national prevalence of 
diabetes in 20094; however, their estimate included only 
four studies measuring the diabetes prevalence in black 
South Africans in two rural, one urban and one metro 
urban population.21–24 The study did not account for 
population variation in diabetes prevalence in South 
Africa,16 19 20 23 and focused on estimating the disability 
burden of diabetes rather than characterising the 
different levels of hyperglycaemia in these populations. 
This review explores availability and quality of diabetes 
prevalence data for South Africa.
Objective
The purpose of this systematic review is to identify, collate 
and synthesise all studies reporting the prevalence of 
diabetes in South Africa. A secondary aim is to report the 
prevalence of impaired glucose tolerance and impaired 
fasting glucose, conditions which are associated with an 
increased risk of progression to overt diabetes, and the 
prevalence of undiagnosed diabetes. These findings will 
be used to inform the Second National Burden of Disease 
study which can guide health and policy planning.
MEthOds
study selection
Published population-based surveys, cross-sectional 
studies and prospective or retrospective cohort studies 
that report the prevalence of diabetes in South Africa.
Inclusion criteria
Studies will be included if they were published between 
January 1997 and February 2018, include more than 100 
participants regardless of age, gender, ethnicity, socioeco-
nomic and educational background and study setting, 
and report the primary outcome using a case definition 
according to the 2006 WHO diagnostic criteria,27 where 
type 2 diabetes is diagnosed either by a physician, fasting 
blood glucose concentrations ≥7.0 mmol/L, 2-hour oral 
glucose tolerance test values ≥11.1 mmol/L or self-re-
ported use of oral diabetes drugs. In addition,  glycated 
haemoglobin ≥6.5% (48 mmol/mol) will also be used 
for case definition.28 Due to limitations that hamper 
the differentiation between type 1 diabetes and type 2 
diabetes, diabetes in individuals older than 25 years of 
age will be classified as type 2 diabetes. Impaired glucose 
tolerance will be defined by fasting blood glucose concen-
trations <7.0 mmol/L and 2-hour oral glucose tolerance 
values ≥7.8 mmol/L, but <11.1 mmol/L. Impaired fasting 
glucose will be defined as fasting blood glucose concentra-
tions between 6.1 mmol/L and 6.9 mmol/L, and, if avail-
able, 2-hour oral glucose tolerance values <7.8 mmol/L.27
Exclusion criteria
Studies will be excluded if they were not conducted in 
South Africa, do not report the primary outcome, have 
no clear description of the case definition and contain 
data for refugees in camps since they may not be repre-
sentative of the South African population.
Primary outcome
Prevalence of type 2 diabetes.
secondary outcome
Prevalence of impaired glucose tolerance, impaired 
fasting glucose and undiagnosed type 2 diabetes.
search strategy
A search of articles written in English and indexed in 
PubMed, Scopus, Web of Science and African Index 
Medicus between January 1997 and February 2018 will 
be conducted. An experienced information scientist and 
disease content experts will be consulted to ensure that 
the search terms are relevant and optimally arranged, and 
will include keywords and medical subject headings . An 
example of the search strategy in PubMed is illustrated 
in table 1. The search will be modified to each database. 
References will be managed in EndNote.
study selection
The titles and abstracts of articles from the electronic 
search outputs will be screened independently by two 
reviewers to identify eligible studies. Disagreements or 
uncertainties will be resolved by discussion and consensus 
between the two reviewers, or with a third reviewer if 
disagreement persists. Full-text copies of the eligible arti-
cles will be retrieved and reviewed by two independent 
reviewers for inclusion. Additional information will be 
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requested from the study authors if required. Reasons for 
exclusion will be recorded.
data extraction
After the final decision to include studies into the review, 
two authors will independently extract and record data 
using the Burden of Disease (BOD) Review Manager 
developed by the South African Medical Research 
Council.29 The following data will be extracted:
► Study details: date of publication, study title, study
design, study period and study purpose.
► Study population: province/district of study, study
setting (community or health facility based), setting
(urban or rural) and sample size.
► Response rate.
► Case definition as reported in the study.
► Prevalence of type 2 diabetes, impaired glucose toler-
ance, impaired fasting glucose and undiagnosed type
2 diabetes.
► Characteristics of study population: age, sex, popula-
tion group (ethnicity) and comorbid disease (tuber-
culosis (TB) or HIV status).
After completion, data will be compared and discrepan-
cies will be resolved through consensus between the two 
reviewers, or in consultation with a third reviewer.
risk of bias assessment
Two reviewers will independently appraise the study 
quality and risk of bias using a checklist for observational 
epidemiological studies that was adapted from the risk of 
bias tool for population-based studies30 and the Newcas-
tle-Ottawa Scale for assessing the quality of non-ran-
domised studies,31 32 and standardised in the BOD Review 
Manager.29 Parameters assessed will include: external 
validity (whether the target population is representative 
of South Africa, representativeness of sample, selection 
criteria and non-response bias) and internal validity (case 
definition, validity and reliability of test instruments, 
consistency of case measurement, appropriateness of 
time period and appropriateness of numerators and 
denominators in estimation). Disagreements between the 
reviewers over the risk of bias will be resolved by discus-
sion with a third reviewer where necessary.
data synthesis
A narrative description will be conducted for studies with 
a low or moderate risk of bias. Clinical heterogeneity will 
be investigated by looking at the characteristics of partic-
ipants, method of diagnosis and case definitions in the 
study.
Subgroup analyses for study population (province/
district, community or health facility based, urban or 
rural) and characteristics of cases (age, sex, population 
group and comorbid disease TB or HIV) will be done 
if sufficient data exists. If possible, a meta-regression 
to explore possible sources of variability in prevalence 
reported between studies will be conducted. Review 
findings will be displayed using tables and forest plots as 
appropriate.
Confidence in cumulative evidence
The strength of evidence will be assessed using the 
Grading of Recommendations Assessment, Development 
and Evaluation method33 which scores studies as very low, 
low, moderate or high based on methodological flaws 
within the included studies, consistency of results across 
diverse studies, precision of estimates and publication 
bias.
Patient and public involvement
Patients and public were not involved.
EthICs And dIssEMInAtIOn
The systematic review does not require ethics clearance 
since published studies with non-identifiable data will be 
used. This review is the first to collate and synthesise all 
the available studies reporting the prevalence of diabetes 
in South Africa and will provide local epidemiological 
data to inform the Second National Burden of Disease 
study which can guide health and policy planning. Find-
ings from the review will be disseminated in a peer-re-
viewed journal article and academic reports according to 
the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses guidelines.34
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Table 1 PubMed search strategy
Search Query
#4 Search ((#3 NOT (animals[mh] NOT 
humans[mh]))) AND (‘1997/01/01’[Date-
Publication]: ‘2018/02/28’[Date-Publication])
#3 Search (#1 AND #2)
#2 Search (South Africa[mh]OR“South 
Africa*”[tiab] OR RSA[tiab] OR Africa, 
Southern[mh:noexp] OR Southern Africa[tiab])
#1 Search (Diabetes[Mesh] OR Diabetes 
mellitus[Mesh] OR Type 2 diabetes 
mellitus[Mesh] OR Type 2 diabetes[Mesh] OR 
Diabetes mellitus, type 2[Mesh] OR Diabetes, 
type 2[Mesh] OR hyperglycemia[Mesh] 
OR Blood glucose[Mesh] OR Hemoglobin 
A, glycosylated[Mesh] OR Glycosylated 
hemoglobin OR Impaired glucose tolerance 
OR Impaired fasting glucose OR Undiagnosed 
diabetes
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